Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human HT-29 colon carcinoma and human CaKi1 renal cell carcinoma xenografts.
Year: 2001
Type: article
Source: PubMed
Authors: B A Teicher, K Menon, E Alvarez, E Galbreath, C Shih, M M Faul
Institution: Eli Lilly (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2474621481
